Enfuse Solutions (ENFUSE)

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Revenue growth of 46.92% shows strong top-line momentum in a competitive IT enabled services market.
• ROCE of 14.76% indicates decent capital efficiency at the operating level despite the net loss.
• Promoter holding of 70.62% aligns management's interests with minority shareholders.
• Latest quarter sales of ₹31 Cr show the business has meaningful scale to build upon.
• Current price of ₹210 is below the 52-week high of ₹284, showing some valuation cooling.

Concerns

• Latest quarter net loss of ₹9 Cr and profit growth of -467.24% show severe earnings deterioration.
• P/E of 0.00 and unavailable book value/ROE make traditional value assessment impossible.
• Piotroski F-Score of 4/9 signals weak financial health and higher bankruptcy risk.
• Zero dividend yield means shareholders expect everything from future capital appreciation, with no income cushion.

AI Analysis

Looking at Enfuse Solutions, I am reminded that price is what you pay, value is what you get. At ₹210, the market cap is ₹173 Cr. But what am I actually getting? The latest quarter shows sales of ₹31 Cr and a net loss of ₹9 Cr. Profit growth collapsed by -467.24%. A P/E of 0.00 is meaningless because there are no earnings to justify the price. Graham would insist on a margin of safety, and a loss-making company does not offer that unless I can see a clear path to profits. Sales growth of 46.92% is attractive, but growth without profit can destroy capital. ROCE of 14.76% suggests the operating capital is being used reasonably at an operating level, yet the bottom line is bleeding. Promoter holding of 70.62% is high and does align interests, but alignment is not the same as a moat. In IT enabled services, switching costs and proprietary advantages matter, and the data given do not reveal any. The Piotroski F-Score of 4/9 underlines weak financial health. There is no dividend, no book value, and no ROE data; this is insufficient transparency for a value investor. The stock sits at ₹210, well below the 52-week high of ₹284 but above the low of ₹148. I don't see a bargain price that compensates for the risk. Until losses narrow and earnings turn positive, this is a show-me story. I will not buy hope; I need evidence.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer